Just a few other thoughts and observations...
The stock price is not the illness, it is a symptom. To focus on the price is not a focus on the problem. Let's wait to analyze the stock price till a time that there is a revenue stream; until then, this analytical effort is meaningless. Once the company commercializes some technologies, the inception to the pre-commercialization date stock price graph will look like a straight line.
In the sprit of the current baseball season, it seems to me that the company is a bit unwilling to take a swing at a pitch in the strike zone that would not be a home run. The team of Gleasmans, coached by an ever changing board of directors and outside managers that get hired and fired (or just submit a resignation) on a regular basis, all participate in the decisions to take the "strikes". Let's just hope that that the only way of getting on base is not a "walk". The only constant seems to be the shareholder's as the team owners. The play by play is being called by persons who don't know or understand the technology or the strategies to win. The team announcements are limited to only the ones that are required by league rules. Thus the stands are bare as the fans tire of waiting for action. The money makers "Vegas" line is controlled by the shorts who have wagered on defeat.
No need to fret, the star players are "Naturals".
I think that the verdict on the JLTV plan is scheduled for sometime later this month.
AI
